Dividends Calendar Earnings Calendar
EBS

EBS | Emergent BioSolutions Inc

Healthcare sector

Emergent BioSolutions Inc

EBS Upgrades / Downgrades

Date Action Broker / Analyst Change Price Target
Apr 10, 2023UpgradeThe Benchmark CompanyHold → Buy$22
Mar 17, 2023DowngradeJP MorganNeutral → Underweight$9
Nov 10, 2022DowngradeThe Benchmark CompanyBuy → Hold
Apr 29, 2022DowngradeCantor FitzgeraldOverweight → Neutral
Jan 20, 2022UpgradeThe Benchmark CompanyHold → Buy$77
Nov 8, 2021DowngradeThe Benchmark CompanyBuy → Hold
May 5, 2021DowngradeArgusBuy → Hold
Apr 7, 2021InitiatedThe Benchmark CompanyBuy $150
Feb 24, 2021UpgradeChardan Capital MarketsNeutral → Buy$112
Feb 19, 2021DowngradeChardan Capital MarketsBuy → Neutral$112
Jan 8, 2021DowngradeWells FargoOverweight → Equal Weight$110
Sep 14, 2020ResumedJP MorganNeutral $103
Jul 31, 2020ReiteratedChardan Capital MarketsBuy $112
Sep 12, 2019InitiatedGuggenheimBuy
Sep 4, 2019UpgradeWells FargoMarket Perform → Outperform


Jump to (Finance sites)

Google   
         

Research 


Investor page

investors.emergentbiosolutions.com

If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


Consensus
BUY 50
HOLD 50
SELL 0

Their Official Profiles 

Wikipedia

Peers / Similar stocks 

xlv 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

The Intelligent Investor
Buy on Amazon

Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

The best book on investing ever written.
-- Warren Buffet